BSE Live
Feb 10, 16:01Prev. Close
26.01
Open Price
27.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
| Key Financial Ratios of ANG Lifesciences India (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | -7.86 | -6.48 | 0.04 | 38.51 | 13.56 | |
| Diluted EPS (Rs.) | -7.86 | -6.48 | 0.04 | 38.51 | 13.56 | |
| Cash EPS (Rs.) | -3.12 | -0.68 | 6.01 | 43.25 | 16.10 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 51.16 | 58.74 | 65.50 | 80.53 | 80.22 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 51.16 | 58.74 | 65.50 | 80.53 | 80.22 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 1.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 68.85 | 100.60 | 158.52 | 336.34 | 297.84 | |
| PBDIT/Share (Rs.) | 0.49 | 7.62 | 16.01 | 63.70 | 27.82 | |
| PBIT/Share (Rs.) | -4.31 | 1.68 | 9.49 | 58.76 | 25.28 | |
| PBT/Share (Rs.) | -9.91 | -6.79 | 1.58 | 51.19 | 19.56 | |
| Net Profit/Share (Rs.) | -7.92 | -6.62 | -0.51 | 38.31 | 13.56 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 0.70 | 7.57 | 10.10 | 18.93 | 9.34 | |
| PBIT Margin (%) | -6.26 | 1.67 | 5.98 | 17.47 | 8.48 | |
| PBT Margin (%) | -14.38 | -6.75 | 0.99 | 15.21 | 6.56 | |
| Net Profit Margin (%) | -11.50 | -6.58 | -0.31 | 11.38 | 4.55 | |
| Return on Networth / Equity (%) | -15.48 | -11.27 | -0.77 | 47.57 | 16.90 | |
| Return on Capital Employed (%) | -6.76 | 2.39 | 11.67 | 53.07 | 25.15 | |
| Return on Assets (%) | -4.95 | -3.97 | -0.26 | 14.78 | 4.89 | |
| Total Debt/Equity (X) | 1.01 | 0.73 | 0.62 | 0.73 | 0.96 | |
| Asset Turnover Ratio (%) | 0.42 | 0.56 | 0.79 | 1.69 | 107.46 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.20 | 1.27 | 1.16 | 1.18 | 1.27 | |
| Quick Ratio (X) | 0.90 | 1.00 | 0.91 | 0.99 | 1.06 | |
| Inventory Turnover Ratio (X) | 2.49 | 2.62 | 4.54 | 9.68 | 8.02 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 2.61 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 2.31 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 97.39 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 97.69 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 93.92 | 109.13 | 146.01 | 297.61 | 80.58 | |
| EV/Net Operating Revenue (X) | 1.04 | 0.83 | 0.71 | 0.85 | 0.52 | |
| EV/EBITDA (X) | 147.55 | 10.97 | 6.98 | 4.51 | 5.59 | |
| MarketCap/Net Operating Revenue (X) | 0.33 | 0.45 | 0.48 | 0.70 | 0.29 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 97.38 | 0.00 | |
| Price/BV (X) | 0.44 | 0.77 | 1.16 | 2.91 | 1.07 | |
| Price/Net Operating Revenue | 0.33 | 0.45 | 0.48 | 0.70 | 0.29 | |
| Earnings Yield | -0.35 | -0.15 | -0.01 | 0.16 | 0.16 |
04.12.2025
ANG Lifescience Consolidated September 2025 Net Sales at Rs 26.05 crore, down 20.77% Y-o-Y
27.11.2025
ANG Lifescience Standalone September 2025 Net Sales at Rs 25.97 crore, down 19.24% Y-o-Y
12.06.2025
ANG Lifescience Standalone March 2025 Net Sales at Rs 17.67 crore, down 48.16% Y-o-Y
04.06.2025
ANG Lifescience Consolidated March 2025 Net Sales at Rs 16.82 crore, down 55.54% Y-o-Y
04.12.2025
ANG Lifescience Consolidated September 2025 Net Sales at Rs 26.05 crore, down 20.77% Y-o-Y
27.11.2025
ANG Lifescience Standalone September 2025 Net Sales at Rs 25.97 crore, down 19.24% Y-o-Y
12.06.2025
ANG Lifescience Standalone March 2025 Net Sales at Rs 17.67 crore, down 48.16% Y-o-Y
04.06.2025
ANG Lifescience Consolidated March 2025 Net Sales at Rs 16.82 crore, down 55.54% Y-o-Y